| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |